172 related articles for article (PubMed ID: 354331)
1. Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
Frangos H; Zissis NP; Leontopoulos I; Diamantas N; Tsitouridis S; Gavriil I; Tsolis K
Acta Psychiatr Scand; 1978 May; 57(5):436-46. PubMed ID: 354331
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
Russell N; Landmark J; Merskey H; Turpin T
Can J Psychiatry; 1982 Nov; 27(7):593-6. PubMed ID: 7172160
[TBL] [Abstract][Full Text] [Related]
3. The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate.
Floru L; Heinrich K; Wittek F
Int Pharmacopsychiatry; 1975; 10(4):230-9. PubMed ID: 814106
[TBL] [Abstract][Full Text] [Related]
4. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
Magnus RV
MMW Munch Med Wochenschr; 1980 Dec; 122(49):1758-60. PubMed ID: 6779147
[No Abstract] [Full Text] [Related]
5. A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
Chouinard G; Annable L; Steinberg S
J Clin Psychopharmacol; 1986 Feb; 6(1):21-6. PubMed ID: 3512622
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
Pinto R; Bannerjee A; Ghosh N
Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
[TBL] [Abstract][Full Text] [Related]
7. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
Faltus F
Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
[No Abstract] [Full Text] [Related]
8. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
Walker CA
Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
[TBL] [Abstract][Full Text] [Related]
9. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
Johnson DA; Malik NA
Acta Psychiatr Scand; 1975 May; 51(4):257-67. PubMed ID: 1096536
[TBL] [Abstract][Full Text] [Related]
11. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
MacCrimmon DJ; Saxena B; Foley P; Grof P
Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
[TBL] [Abstract][Full Text] [Related]
12. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Wistedt B; Ranta J
Acta Psychiatr Scand; 1983 Jun; 67(6):378-88. PubMed ID: 6349256
[TBL] [Abstract][Full Text] [Related]
13. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
Malm U; Perris C; Rapp W; Wedrén G
Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
[No Abstract] [Full Text] [Related]
14. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Cookson JC; Kennedy NM; Gribbon D
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
[TBL] [Abstract][Full Text] [Related]
15. [The depot neuroleptic agent fluspirilene (author's transl)].
Angst J; Frei M; Scharfetter Chr
Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
[No Abstract] [Full Text] [Related]
16. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Kong DS; Yeo SH
Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
[TBL] [Abstract][Full Text] [Related]
17. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
Wistedt B
Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
[TBL] [Abstract][Full Text] [Related]
18. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
Winter K; Fullerton AG; Hussain K; Tarlo L
Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
[No Abstract] [Full Text] [Related]
19. Fluspirilene: a long-acting injectable neuroleptic.
Drug Ther Bull; 1977 Jul; 15(15):59-60. PubMed ID: 330126
[No Abstract] [Full Text] [Related]
20. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
Kissling W; Möller HJ; Walter K; Wittmann B; Krueger R; Trenk D
Pharmacopsychiatry; 1985 May; 18(3):240-5. PubMed ID: 4011672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
